Real Chemistry Press Releases

• Published on October 10, 2024 - 07:00 GMT

  Headway revela que aumentar la inversión en salud mental puede evitar costes de más de €122.000 millones en Europa

  BRUSSELS, BELGIUM, October 10, 2024 /⁨EINPresswire.com⁩/ -- El nuevo informe Headway revela que aumentar la inversión en atención de salud mental puede evitar costes de más de 122.000 millones de euros en toda Europa • Los hallazgos clave de esta …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Politics ...
• Published on September 19, 2024 - 16:01 GMT

  Angelini Pharma presenta i dati a lungo termine su cenobamato

  Angelini Pharma presenta i dati a lungo termine su cenobamato che dimostrano un beneficio prolungato negli adulti con epilessia ROME, ITALY, September 19, 2024 /⁨EINPresswire.com⁩/ -- • I risultati di un’analisi post-hoc dello studio di estensione in …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on September 19, 2024 - 16:00 GMT

  Angelini Pharma Presents Long-Term Data for cenobamate▼ Demonstrating Benefit in Adults Living with Epilepsy

  ROME, ITALY, September 19, 2024 /⁨EINPresswire.com⁩/ -- - Findings from a post-hoc analysis of the C017 open-label extension (OLE) study demonstrated long-term reduction in seizure frequency with cenobamate, approved as adjunctive treatment in patients …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...